Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase April 24, 2024 8:00am EDT Download as PDF CHATHAM, N.J., April 24, 2024 (GLOBE NEW
Tonix PharmaceuticalsApr 24 00:00 ET
Express News | WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC Alone, More Than 4500 Cases of #mpox and Almost 300 Deaths Have Been Reported This Year. That Is Triple the Number Reported at This Time Last Year. The Recent Surge in Cases and Deaths Among Children Is
Moomoo 24/7Apr 11 10:09 ET
Express News | Tonix Pharmaceuticals Q4 EPS $(0.86) Beats $(1.55) Estimate, Sales $3.80M Miss $5.75M Estimate
Moomoo 24/7Apr 1 16:28 ET
Tonix Pharmaceuticals 4Q Loss/Shr 86c >TNXP
Tonix Pharmaceuticals 4Q Loss/Shr 86c >TNXP
Dow JonesApr 1 16:15 ET
Press Release: Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided an overview of recent operational highlights.
Dow JonesApr 1 16:15 ET
Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On?
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares traded lower by 7.2% to $0.17 Monday morning, hitting a new-all time low. The stock is trading lower on downward momentum after the company last
BenzingaApr 1 10:43 ET
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAvalo Therapeutics (NASDAQ:AVTX) shares increased by 364.8% to $22.08 during Friday's regular session. The market value of their outstanding shares is at $17.6 million. Nexalin Technology (NASD
BenzingaMar 29 12:30 ET
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading lower by 33.9% to $0.22 Thursday afternoon after the company announced the pricing of a $4.4 million registered direct offering.Toni
BenzingaMar 28 13:02 ET
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersAvalo Therapeutics (NASDAQ:AVTX) stock rose 363.1% to $22.0 during Thursday's regular session. The company's market cap stands at $17.6 million. Xilio Therapeutics (NASDAQ:XLO) stock rose 133.9
BenzingaMar 28 12:31 ET
Express News | Tonix Pharmaceuticals Holding Shares Are Trading Lower After the Company Announced the Pricing of a $4.4 Million Registered Direct Offering
Moomoo 24/7Mar 28 11:21 ET
Express News | Tonix Pharmaceuticals Prices $4.4M Registered Direct Offering Of 14,666,666 Shares And Warrants At $0.30/Share; Warrants Have Exercise Price Of $0.33/Share
Moomoo 24/7Mar 28 09:35 ET
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering March 28, 2024 9:32am EDT Download as PDF CHATHAM, N.J., March 28, 2024
Tonix PharmaceuticalsMar 28 00:00 ET
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation From The FDA For TNX-2900 For The Treatment Of Prader-Willi Syndrome
TNX-2900 is a proprietary magnesium-potentiated formulation of intranasal oxytocin, a naturally occurring hormone that reduces appetite and eating
moomoo NewsMar 25 08:06 ET
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation From the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome March 25, 2024 8:00am EDT Download a
Tonix PharmaceuticalsMar 25 00:00 ET
Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting
Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting March
Tonix PharmaceuticalsMar 21 00:00 ET
Tonix Picks CMOs for Potential Launch of Fibromyalgia Drug
Seeking AlphaMar 20 13:02 ET
Express News | Tonix Pharmaceuticals Announces Selection Of Two Contract Manufacturing Organizations For The Launch And Commercial Manufacture Of Tonmya For Management Of Fibromyalgia; NDA Submission Planned For 2H Of 2024
Moomoo 24/7Mar 20 08:04 ET
Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for The...
Stockhouse Mar 20 08:00 ET
Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya for the Management of Fibromyalgia
Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya for the Management of Fibromyalgia March 20,
Tonix PharmaceuticalsMar 20 00:00 ET
Tonix Pharmaceuticals Announces Transition To Fully Integrated Biopharmaceutical Company Expected On April 1, 2024
Zembrace SymTouch and Tosymra will be marketed by Tonix Medicines, Tonix's wholly-owned commercial subsidiaryCommercial capabilities prepare Tonix for the potential launch in 2025 of Tonmya for the ma
BenzingaMar 19 08:04 ET
No Data
No Data